Intel Corporation (NASDAQ: INTC) Q2 2021 earnings call dated Jul. 22, 2021
Corporate Participants:
Tony Balow — Head, Investor Relations
Pat Gelsinger — Chief Executive Officer
George Davis — Chief Financial Officer
Analysts:
Timothy Arcuri — UBS — Analyst
C.J. Muse — Evercore — Analyst
John Pitzer — Credit Suisse — Analyst
Stacy Rasgon — Bernstein — Analyst
Joe Moore — Morgan Stanley — Analyst
Vivek Arya — Bank of America — Analyst
Matt Ramsay — Cowen — Analyst
Harlan Sur — JPMorgan — Analyst
Toshiya Hari — Goldman Sachs — Analyst
Srini Pajjuri — SMBC Nikko — Analyst
Tristan Gerra — Baird — Analyst
Ross Seymore — Deutsche Bank — Analyst
Ambrish Srivastava — BMO Capital Markets — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Listen On
